Shkreli is being charged for illegally using Retrophin assets to pay off debts after MSMB lost millions of dollars.
The indictment said Shkreli and Greebel, along with others, orchestrated three interrelated fraud schemes from September 2009 through September 2014.
It said they fraudulently induced investors to invest in two separate funds and misappropriated the assets of publicly traded Retrophine to satisfy Shkreli's personal and unrelated professional debt obligations.
Capers said Shkreli had a history of duping investors in one hedge fund to pay off debts from another, and instead of coming clean, continued with his scheme.
"He did that to conceal the lies he told, namely, that their investments were doing well and they were getting handsome returns," Capers added.
"The $65 million Retrophin wants from me would not dent me," a defiant Shkreli previously told Bloomberg Businessweek about the suit.
"I feel great. I'm licking my chops over the suits I'm going to file against them."
http://www.nbcnews.com/business/business-news/fbi-arrests-controversial-turing-pharmaceuticals-ceo-martin-shkreli-report-n481671